Skip to Content

Division of Pediatrics - Division Priority List

MD Anderson

Pediatric Clinical Trials

  

Disease Type Phase / Type Title Physician Contact / Phone Protocol Number
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Acute Lymphoblastic Leukemia (ALL)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Acute Myelogenous Leukemia (AML)
   II Thiotepa-Clofarabine-Busulfan with Allogeneic and Haploidentical Stem Cell Transplant for High Risk Malignancies Worth, Laura L., M.D., Ph.D. Woodworth, Glenda G., R.N.
(713) 795-2058
2008-0363
Cell Therapy
   I A Phase I Study of ALT-801 for Ex Vivo Maturation and In Vivo Retargeting of Haploidentical Natural Killer Cells Delivered Following Fludarabine, Cytarabine, and G-CSF in Patients with Relapsed/Refractory Acute Myeloid Leukemia Lee, Dean A., M.D., Ph.D. Poon, Man-Yin
(713) 563-1781
2008-0450
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Aplastic Anemia
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Brainstem Glioma/ Pontine Glioma
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Central Nervous System (CNS)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Central Nervous System/Brain Tumors
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Chronic Lymphocytic Leukemia
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Chronic Myeloid Leukemia (CML)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Ependymoma
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Hodgkin's Disease
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Laboratory
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Medulloblastoma/Primitive Neuroectodermal Tumors (PNET)/Embryonal Tumors
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Non-Hodgkin's Lymphoma
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Other
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Other, Blood/BM Collection
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML)  Pediatric Tumors/Conditions